Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now     
Bio B2B 〉Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc.

Chat Now My Favorites
Invested by Taiwan Government--the Ministry of Economic Affairs--in 2000, Taiwan Advance Bio-Pharmaceutical Incorporation (TABP) is the first biotechnology company in Taiwan, specializing in the food and feed diagnostic kits. Till now TABP has over 60 product lines, whose range cover most common used chemical compounds such as ractopamine and tetracycline, and a 90% domestic market share. The key features about TABP's diagnostic kits include:
  • Easy to use
In order to satisfy the need of on-site monitor and large-scale screening, TABP's kits focus on immune assay (ELISA and test strips), which has high sensitivity and a lower cost.
  • Customized manufacture
With the special technique, TABP provides one line service from immunogen design and production, animal immunity, serum filtration, ELISA or stripes platform design and product manufacture.
 

Moreover, TABP expands the research fields to drug abuse examination, stem cells storage service, gene testing service, protein drug and stem cells proliferation research, and has accomplishments in every field. The latest achievement is that the stem cells proliferation technique has passed stability test and face clinical trial in the coming years.
 
  • Wen-Lung, SU<br/>President and CEO

    Wen-Lung, SU
    President and CEO

     CEO, Advance Biotechnology Club Inc.
     Biotech Consultant , Taipei City Government
  • Chi-Hung, HUANG<br/>Vice President

    Chi-Hung, HUANG
    Vice President

     Executive Director, GlycoNex Inc.
     Ph. D., National Chung Hsing University
Invested by Taiwan Government--the Ministry of Economic Affairs--in 2000, Taiwan Advance Bio-Pharmaceutical Incorporation (TABP) is the first biotechnology company in Taiwan, specializing in the food and feed diagnostic kits. Till now TABP has over 60 product lines, whose range cover most common used chemical compounds such as ractopamine and tetracycline, and a 90% domestic market share. The key features about TABP's diagnostic kits include:
  • Easy to use
In order to satisfy the need of on-site monitor and large-scale screening, TABP's kits focus on immune assay (ELISA and test strips), which has high sensitivity and a lower cost.
  • Customized manufacture
With the special technique, TABP provides one line service from immunogen design and production, animal immunity, serum filtration, ELISA or stripes platform design and product manufacture.
 

Moreover, TABP expands the research fields to drug abuse examination, stem cells storage service, gene testing service, protein drug and stem cells proliferation research, and has accomplishments in every field. The latest achievement is that the stem cells proliferation technique has passed stability test and face clinical trial in the coming years.